Commerzbank Aktiengesellschaft FI Increases Stock Holdings in MetLife, Inc. $MET

Key Points

• Commerzbank Aktiengesellschaft FI increased its stake in MetLife, Inc. by 180% during the 2nd quarter, now holding 155,036 shares valued at approximately $12.47 million.
• MetLife reported $2.02 EPS for the recent quarter, falling short of analysts' expectations of $2.32, with a revenue of $17.34 billion, which was below the projected $18.58 billion.
• The company announced a quarterly dividend of $0.5675 per share, scheduled for payment on December 9, representing an annualized yield of 2.8%.

Commerzbank Aktiengesellschaft FI boosted its position in MetLife, Inc. (NYSE:MET - Free Report) by 180.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 155,036 shares of the financial services provider's stock after purchasing an additional 99,674 shares during the period. Commerzbank Aktiengesellschaft FI's holdings in MetLife were worth $12,468,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Kathmere Capital Management LLC increased its holdings in MetLife by 88.2% in the 2nd quarter. Kathmere Capital Management LLC now owns 6,328 shares of the financial services provider's stock worth $509,000 after acquiring an additional 2,965 shares in the last quarter. First Horizon Advisors Inc. increased its holdings in MetLife by 4.8% in the 1st quarter. First Horizon Advisors Inc. now owns 422,684 shares of the financial services provider's stock worth $33,937,000 after acquiring an additional 19,192 shares in the last quarter. Ritholtz Wealth Management increased its holdings in MetLife by 52.1% in the 1st quarter. Ritholtz Wealth Management now owns 9,355 shares of the financial services provider's stock worth $751,000 after acquiring an additional 3,204 shares in the last quarter. Pinnacle Financial Partners Inc purchased a new stake in MetLife in the 1st quarter worth approximately $255,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in MetLife by 20.7% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 60,785 shares of the financial services provider's stock worth $4,735,000 after acquiring an additional 10,414 shares in the last quarter. 94.99% of the stock is owned by hedge funds and other institutional investors.

MetLife Price Performance

Shares of MetLife stock opened at $81.94 on Friday. The stock has a market cap of $54.49 billion, a price-to-earnings ratio of 13.89, a price-to-earnings-growth ratio of 0.74 and a beta of 0.86. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a 50 day moving average price of $79.56 and a 200-day moving average price of $78.18. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05.

MetLife (NYSE:MET - Get Free Report) last announced its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). The company had revenue of $17.34 billion during the quarter, compared to analysts' expectations of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.MetLife's revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter last year, the firm posted $2.28 EPS. Equities analysts expect that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be issued a $0.5675 dividend. The ex-dividend date is Tuesday, November 4th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.8%. MetLife's payout ratio is 38.47%.

Analyst Ratings Changes

MET has been the subject of several analyst reports. Wolfe Research raised shares of MetLife to a "strong-buy" rating in a report on Tuesday, September 16th. Morgan Stanley lifted their target price on MetLife from $94.00 to $97.00 and gave the company an "overweight" rating in a research note on Tuesday. Weiss Ratings reissued a "buy (b)" rating on shares of MetLife in a report on Wednesday. Jefferies Financial Group boosted their price target on MetLife from $100.00 to $103.00 and gave the stock a "buy" rating in a report on Monday, August 11th. Finally, UBS Group lowered their price target on MetLife from $94.00 to $91.00 and set a "buy" rating on the stock in a report on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, MetLife currently has a consensus rating of "Moderate Buy" and a consensus price target of $95.18.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.